Physician

Wassim Salem Saikali, MD

According to 2025 Medicare claims, Wassim Saikali, MD (NPI: 1992755201) practices rheumatology in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is RHEUMATOLOGY AND PULMONARY CLINIC PLLC (NPI: 1467439463; TIN: 550775651) and primary practice location at 25801-9998. Saikali is affiliated with the ACO West Virginia (ACO ID: A3563) and Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Saikali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 926 traditional Medicare patients, billed 140,249 HCPCS/CPT codes, and received $1,935,484 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,700 prescription claims across 1,222 beneficiaries totaling $12,223,546 in drug costs, led by Enbrel Sureclick (Etanercept). 2023 DME data shows 12 claims. Open Payments data shows 452 records totaling $1,376,079. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,265,633 to $1,935,484. Similarly, Part D prescription costs have risen steadily, from $2,789,898 to $12,223,546. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $1,265,633 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,275,347 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,386,787 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,573,370 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,818,019 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,378,248 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,578,167 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,956,899 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,547,408 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,935,484 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,525103,629$1,265,633
20161,49189,393$1,275,347
20171,33678,671$1,386,787
20181,255102,608$1,573,370
20191,210137,570$1,818,019
20201,130157,998$2,378,248
20211,123167,315$2,578,167
20221,032136,350$1,956,899
2023977140,216$1,547,408
2024926140,249$1,935,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.1M$12M2015 Drug cost: $2,789,898 (USD; Tot_Drug_Cst)2016 Drug cost: $5,492,356 (USD; Tot_Drug_Cst)2017 Drug cost: $7,100,528 (USD; Tot_Drug_Cst)2018 Drug cost: $5,842,107 (USD; Tot_Drug_Cst)2019 Drug cost: $6,050,338 (USD; Tot_Drug_Cst)2020 Drug cost: $6,550,826 (USD; Tot_Drug_Cst)2021 Drug cost: $6,601,392 (USD; Tot_Drug_Cst)2022 Drug cost: $7,913,437 (USD; Tot_Drug_Cst)2023 Drug cost: $9,014,957 (USD; Tot_Drug_Cst)2024 Drug cost: $12,223,546 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,23613,723$2,789,898
20161,16113,233$5,492,356
20171,15012,184$7,100,528
20181,07710,498$5,842,107
20191,0389,028$6,050,338
20201,0769,337$6,550,826
20211,1219,617$6,601,392
20221,0979,206$7,913,437
20231,1539,039$9,014,957
20241,2229,700$12,223,546

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$271$5412017 Medicare payment: $541 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$541
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R12$230
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more493872$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6221,036$60
20610Aspiration and/or injection of fluid from large joint154306$52
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle136256$48
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg125861$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept35310,287$2,722,893
Humira(Cf) PenAdalimumab3109,620$2,460,338
CortrophinCorticotropin30835$1,728,175
RinvoqUpadacitinib772,490$539,705
Xeljanz XrTofacitinib Citrate722,160$416,689

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.298$129,416Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.154$1,246,663Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wassim Salem Saikali, MD?

Tedicare shows public-source Medicare data for Wassim Salem Saikali, MD (NPI 1992755201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wassim Salem Saikali, MD have ACO affiliation data?

Wassim Salem Saikali, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Wassim Salem Saikali, MD?

Wassim Salem Saikali, MD is linked to RHEUMATOLOGY AND PULMONARY CLINIC PLLC (billing NPI 1467439463) in the available physician profile data.

Does Wassim Salem Saikali, MD have Open Payments data?

Wassim Salem Saikali, MD has 452 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.